BioCentury
ARTICLE | Clinical News

BTI-320: Phase IIb data

November 24, 2014 8:00 AM UTC

Top-line data from the double-blind, placebo-controlled, 3-way crossover, U.S. Phase IIb SD-002 trial in 23 Type II diabetics on a stable dose of daily metformin showed that 8 patients responded to BT...